NCT00838877View on ClinicalTrials.gov

Positron Emission Tomography (PET) Study With [18F]AZD4694 and [11C]AZD2184, Candidate PET Ligands for Aβ Amyloid

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2009

Study Completion Date

October 31, 2009

Conditions
Alzheimer's Disease
Interventions
DRUG

radioligand [18F]AZD4694

single dose of iv. admin. 1-2 times per subject

DRUG

radioligand [11C]AZD2184

single dose of iv admin. 1 time per subject

Trial Locations (2)

Unknown

Research Site, Huddinge

Research Site, Stockholm

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY